Life Science Investing Relay Therapeutics Announces Efficacy Subset Analysis of Zovegalisib + Fulvestrant in Breast Cancer Patients Pre-Treated with SERD or with ESR1 Mutations at SABCS 2025
Life Science Investing Relay Therapeutics Reports Third Quarter 2025 Financial Results and Corporate Updates
Life Science Investing Relay Therapeutics to Participate in Two Upcoming Investor Conferences in November
Life Science Investing Relay Therapeutics to Announce Third Quarter 2025 Financial Results and Corporate Highlights on November 6, 2025
Life Science Investing Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September
Surface Metals Inc. Sells Remaining Interest in Manitoba Lithium Project to Earn-in Partner Snow Lake Energy
Nine Mile Metals Announces Completion of DDH WD-25-02B and Continues to Confirm Zones of Copper Rich VMS with 66 Meters of Mineralization at the Wedge Project
